These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 31100979)

  • 1. Current Mechanistic and Pharmacodynamic Understanding of Melanocortin-4 Receptor Activation.
    Sharma S; Garfield AS; Shah B; Kleyn P; Ichetovkin I; Moeller IH; Mowrey WR; Van der Ploeg LHT
    Molecules; 2019 May; 24(10):. PubMed ID: 31100979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal cAMP Signaling Selectivity by Natural and Synthetic MC4R Agonists.
    Molden BM; Cooney KA; West K; Van Der Ploeg LH; Baldini G
    Mol Endocrinol; 2015 Nov; 29(11):1619-33. PubMed ID: 26418335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SHU9119 and MBP10 are biased ligands at the human melanocortin-4 receptor.
    Dai HC; Ji RL; Tao YX
    Biochem Pharmacol; 2024 Oct; 228():116325. PubMed ID: 38815629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanocortin 4 receptor activation induces brain-derived neurotrophic factor expression in rat astrocytes through cyclic AMP-protein kinase A pathway.
    Caruso C; Carniglia L; Durand D; Gonzalez PV; Scimonelli TN; Lasaga M
    Mol Cell Endocrinol; 2012 Jan; 348(1):47-54. PubMed ID: 21803120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MC4R Variants Modulate α-MSH and Setmelanotide Induced Cellular Signaling at Multiple Levels.
    Rodríguez Rondón AV; Welling MS; van den Akker ELT; van Rossum EFC; Boon EMJ; van Haelst MM; Delhanty PJD; Visser JA
    J Clin Endocrinol Metab; 2024 Sep; 109(10):2452-2466. PubMed ID: 38567654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential Signaling Profiles of MC4R Mutations with Three Different Ligands.
    Paisdzior S; Dimitriou IM; Schöpe PC; Annibale P; Scheerer P; Krude H; Lohse MJ; Biebermann H; Kühnen P
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32059383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substituted NDP-MSH peptides paired with mutant melanocortin-4 receptors demonstrate the role of transmembrane 6 in receptor activation.
    Fleck BA; Ling N; Chen C
    Biochemistry; 2007 Sep; 46(37):10473-83. PubMed ID: 17713970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of MAPK by inverse agonists in six naturally occurring constitutively active mutant human melanocortin-4 receptors.
    Mo XL; Tao YX
    Biochim Biophys Acta; 2013 Dec; 1832(12):1939-48. PubMed ID: 23791567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pertussis toxin-sensitive signaling of melanocortin-4 receptors in hypothalamic GT1-7 cells defines agouti-related protein as a biased agonist.
    Büch TR; Heling D; Damm E; Gudermann T; Breit A
    J Biol Chem; 2009 Sep; 284(39):26411-20. PubMed ID: 19648111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural Complexity and Plasticity of Signaling Regulation at the Melanocortin-4 Receptor.
    Kleinau G; Heyder NA; Tao YX; Scheerer P
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32785054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biased signaling initiated by agouti-related peptide through human melanocortin-3 and -4 receptors.
    Yang Z; Tao YX
    Biochim Biophys Acta; 2016 Sep; 1862(9):1485-94. PubMed ID: 27208795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of melanocortin-4 receptor signaling: agonist-mediated desensitization and internalization.
    Shinyama H; Masuzaki H; Fang H; Flier JS
    Endocrinology; 2003 Apr; 144(4):1301-14. PubMed ID: 12639913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of differential melanocortin 4 receptor agonist profiles at natively expressed receptors in rat cortical astrocytes and recombinantly expressed receptors in human embryonic kidney cells.
    Selkirk JV; Nottebaum LM; Lee J; Yang W; Foster AC; Lechner SM
    Neuropharmacology; 2007 Feb; 52(2):459-66. PubMed ID: 17095023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological chaperones restore function to MC4R mutants responsible for severe early-onset obesity.
    René P; Le Gouill C; Pogozheva ID; Lee G; Mosberg HI; Farooqi IS; Valenzano KJ; Bouvier M
    J Pharmacol Exp Ther; 2010 Dec; 335(3):520-32. PubMed ID: 20826565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melanocortin 4 receptors interact with antimicrobial frog peptide analogues.
    Do EU; Jo EB; Choi G; Piao LZ; Shin J; Seo MD; Kang SJ; Lee BJ; Kim KH; Kim JB; Kim SI
    Biochem Biophys Res Commun; 2006 May; 343(4):1094-100. PubMed ID: 16579969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural analysis of setmelanotide binding to MC4R variants in comparison to wild-type receptor.
    Hammad MM; Mohammad A; Alam-Eldin N; Madhu D; Al-Mulla F; Abu-Farha M; Abubaker J
    Life Sci; 2022 Oct; 307():120857. PubMed ID: 35931197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melanocortin-4 receptor agonists for the treatment of obesity.
    Emmerson PJ; Fisher MJ; Yan LZ; Mayer JP
    Curr Top Med Chem; 2007; 7(11):1121-30. PubMed ID: 17584132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constitutive activity in melanocortin-4 receptor: biased signaling of inverse agonists.
    Tao YX
    Adv Pharmacol; 2014; 70():135-54. PubMed ID: 24931195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanocortin-4 receptor activation promotes insulin-stimulated mTOR signaling.
    Chai B; Li JY; Zhang W; Wu X; Zhang C; Mulholland MW
    Peptides; 2010 Oct; 31(10):1888-93. PubMed ID: 20603172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melanocortin 4 receptor activation inhibits presynaptic N-type calcium channels in amygdaloid complex neurons.
    Agosti F; López Soto EJ; Cabral A; Castrogiovanni D; Schioth HB; Perelló M; Raingo J
    Eur J Neurosci; 2014 Sep; 40(5):2755-65. PubMed ID: 24943127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.